Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04669002
Title EP0057 in Combination With Olaparib in Advanced Ovarian Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Ellipses Pharma
Indications

ovarian serous carcinoma

ovarian endometrial cancer

fallopian tube cancer

peritoneum cancer

Therapies

CRLX101 + Olaparib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.